Evommune
Evommune is taking a tissue-based approach to insights and accelerating the development of transformative medicines for inflammatory diseases. Evommune creates novel strategies to treat inflammatory disorders by developing treatments that address symptoms while also halting disease progression. Evommune's pipeline contains initiatives aimed at combating highly prevalent inflammatory illnesses. Its mission is to drive real advancements for patients suffering from these diseases, with all of its programs designed to produce best-in-class profiles.
Domain
evommune.com
Country
United StatesIndustry
BiotechnologyEmployees
11-50
Last Funding
$125.0M
Founded
2019
Tech Stack (20 technologies)
Frequently Asked Questions
What technologies does Evommune use?+
Evommune uses 20 technologies including AOS, Divi, Font Awesome.
What industry is Evommune in?+
Evommune operates in the Biotechnology industry.
Where is Evommune based?+
Evommune is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026